Table 12.
Placebo ∆ | Chitosan ∆ | p-Value Chitosan vs. Placebo | |
---|---|---|---|
All subjects (μg/mg) | −0.04 ± 0.25 | −0.04 ± 0.16 | 0.3616 # |
% subjects decrease | 52.7 | 62.3 | 0.3485 # |
% subjects increase | 47.3 | 37.7 | |
Change vs. baseline | |||
Spearman R | −0.2577 | −0.5399 | |
Spearman p-value | 0.0575 | p < 0.0001 | |
Difference in slope (p-value) | <0.0001 $ | 0.0002 $ | 0.8998 & |
∆ Wilcoxon p-value expressing the significance of the change compared to zero, # data are expressed as p-values using the Mann–Whitney test, $ value expresses whether slope is different from zero, & value expresses whether slopes under chitosan and placebo treatments are different.